Wuxi AppTec, Asia’s largest provider of contract pharmaceutical research, posted net income that smashed market expectations in the first half of the year amid strong demand tied to weight-loss and diabetes drugs, as well as gains in its US business.
Interim net profit attributable to the owners of the Shanghai-based drug contractor advanced 33.7 per cent to 11.08 billion yuan (...
Following South China Morning Post - Companies's news feed is very easy. Subscribe using the "follow" button on the top right and if you want to, choose the updates by topic or tag.
We will deliver them to your inbox, your phone, or you can use Specificfeeds like your own online RSS reader. You can unsubscribe whenever you want with one click.
Keep up to date with South China Morning Post - Companies!
South China Morning Post - Companies: International Edition | South China Morning Post